Retinal Vascular Disease & Sudden Painless Loss
Treat acute retinal ischaemia as a time-critical vascular presentation and distinguish venous disease.
20 learning units • 100 chapter sections • 200 explained questions. Assess visual symptoms, recognise sight-threatening disease and plan safe treatment, referral and follow-up.
Treat acute retinal ischaemia as a time-critical vascular presentation and distinguish venous disease.
Quick revision ↓ Medical Dictionary
Sudden painless monocular loss requires urgent assessment of retinal, optic nerve and vascular causes. Record the time last known well, acuity, pupils and relevant neurological symptoms. A quiet white eye does not exclude an emergency. Use an emergency pathway rather than waiting for routine outpatient imaging to identify the cause.
Acute retinal artery occlusion is a retinal ischaemic emergency requiring immediate ophthalmic and stroke-service assessment. Fundus signs may include retinal whitening, but early or incomplete findings must not delay escalation. Specialist teams assess reperfusion eligibility, embolic sources and secondary prevention. Unproven bedside measures must not delay transfer to the appropriate emergency service.
A temporary blackout can reflect retinal ischaemia even when vision has returned. Clarify whether the event was truly monocular, its duration and associated neurological symptoms. Prompt vascular or TIA assessment remains necessary when ischaemia is suspected. Do not label every transient visual event as migraine, particularly when the pattern is new or atypical.
Retinal vein occlusion can cause painless blur with haemorrhages and venous changes on fundus examination. Macular oedema and retinal ischaemia influence visual outcome. Ophthalmic treatment may target oedema or neovascular complications, while systemic assessment addresses factors such as blood pressure and diabetes. Arterial and venous occlusions are not interchangeable diagnoses or treatment pathways.
In an older adult, visual loss with new headache, scalp tenderness or jaw claudication raises concern for giant cell arteritis. Arrange immediate medical and ophthalmic assessment and clinician-directed treatment; confirmatory testing must not delay treatment when strongly suspected. Follow-up after vascular eye disease should include both visual complications and systemic vascular risk management.
Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.
Reference review: 28 September 2026. Consult current local protocols for prescribing, procedures and escalation.